ARAY — ACCURAY INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1138723 ·
Last close
$0.27
Market Cap
$32.25M
52W High
$0.49
52W Low
$0.22
ADV30
1,911,220
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 104,845,000 | 25,294,000 | -2,548,000 | -11,805,000 | 447,602,000 | 38,067,000 | 405,895,000 |
| Dec 2025 | 102,241,000 | 24,072,000 | -5,491,000 | -13,770,000 | 448,009,000 | 41,295,000 | 394,589,000 |
| Sep 2025 | 93,942,000 | 26,548,000 | -11,313,000 | -21,678,000 | 456,816,000 | 63,344,000 | 394,949,000 |
| Jun 2025 | 127,543,000 | 38,979,000 | 4,234,000 | 1,123,000 | 470,239,000 | 57,416,000 | 389,070,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,116,000
Investing CF
$-14,328,000
Financing CF
$-2,492,000
CapEx
$-14,328,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-566,525,000
Inventory
$156,626,000
Receivables
$80,579,000
ST Investments
—
EBIT TTM
$-15,237,000
Pretax Income TTM
$-43,670,000
Interest Exp TTM
$28,433,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$428,571,008
EBITDA
$-5,592,000
Free Cash Flow
$-10,882,000
Enterprise Value
$176,224,160
Total Cash
$38,067,000
Total Debt
$182,396,992
Shares Out
119,433,440
Trailing EPS
$-0.38
Book Value
$0.35
ROE
-101.1%
ROA
-1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 458,505,000 | 7,839,000 | -1,591,000 | 470,239,000 | 389,070,000 | — | 2,860,000 |
| Jun 2024 | 446,551,000 | 504,000 | -15,545,000 | 468,627,000 | 423,543,000 | — | -11,904,000 |
| Jun 2023 | 447,605,000 | 2,382,000 | -9,280,000 | 479,214,000 | 425,555,000 | — | 15,539,000 |
| Jun 2022 | 429,909,000 | 8,148,000 | -5,347,000 | 472,849,000 | 419,660,000 | — | -2,400,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.24
Max Pain — expiry 2026-09-18
max pain strike: $0.50 · spot: $0.27 · call oi: 4,353 · put oi: 9
Expected Move to 2026-09-18:
±$0.27
(101.85%) —
implied range
$-0.00 –
$0.55
· ATM straddle on $0.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TELA | TELA Bio, Inc. | $32.68M | $0.73 | — |
| BDMD | Baird Medical Investment Holdings Ltd | $32.94M | $1.03 | — |
| VASO | VASO Corp | $33.44M | $0.19 | — |
| NSPR | InspireMD, Inc. | $30.45M | $0.65 | — |
| NTRB | NutriBand Inc. | $34.64M | $2.85 | — |
News headlines (Yahoo Finance, 1h cache)
Sector Update: Healthcare Stocks Decline Thursday Afternoon
2026-07-30 17:35 · Yahoo
Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity
2026-07-30 15:08 · Yahoo
Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation
2026-07-29 22:26 · Yahoo
Accuray (ARAY) Stock Sees Fair Value Cut After Downgrades And Lower Growth Assumptions
2026-06-27 05:06 · Yahoo
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
2026-05-29 20:10 · Yahoo
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
2026-05-15 20:05 · Yahoo
Accuray Inc (ARAY) Runs Into Middle East Headwinds, But Shift Plan Is Working
2026-05-12 18:04 · Yahoo
Toast downgraded, Lowe's upgraded: Wall Street's top analyst calls
2026-05-12 13:56 · Yahoo
Accuray Slides As Insider Purchases Lose Another US$95k
2026-05-11 10:51 · Yahoo
Accuray (ARAY) Q3 2026 Earnings Transcript
2026-05-06 22:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.